13:34 · 28 October 2025

DE40: DAX near 1-week high 📈Deutsche Borse lags, SUSS MicroTec slides 23%

Key takeaways
DE40
Indices
-
-
SUESS MicroTec
Shares
SMHN.DE, SUESS MicroTec SE
-
-
Deutsche Boerse
Shares
DB1.DE, Deutsche Boerse AG
-
-
Key takeaways
  • DAX fluctuates at 1-week high
  • Symrise and SUSS MicroTec slide after earnings
  • Nordex shares surge 19% 
  • Deutsche Borse stock well below EMA200 despite solid earnings report

Sentiments across the German stock market are slightly better today, amid positive sentiments on Wall Street. European stocks rise. German chancellor, Friedrich Merz backed up the Pan-European stock exchange initiative, aimed to rival US and Chinese stock markets.

DE40

Futures on DAX (DE40) are up almost 0.3% today, rising above 24400 points, respecting EMA50 (the orange line). 

 

Source: xStation5

SUSS MicroTec (D1 interval)

 

Deutsche Bank has lowered its price target for SUSS MicroTec SE from €41 to €36, keeping a Hold rating after the company issued its second profit warning of 2025. While sales came in solid — around €118 million, about 4–5% above expectations — margins collapsed, revealing the real pain point. The gross margin dropped to 33.1%, well below the 38–39% range analysts had forecast, pulling the EBIT margin down to just 10.5%. According to Deutsche Bank, the sharp decline reflects both a less favorable product mix and ramp-up costs from the new Taiwan fab, which are weighing on near-term profitability. Top-line growth isn’t the issue — margins are. Actually, a stock is almost 30% below its EMA200.

 

Source: xStation5

Deutsche Borse (D1 interval) Stock Beats Expectations, Calms Fears on Treasury Drag

Deutsche Boerse AG (DB1:GR) posted a solid Q3 2025 performance, edging past analyst forecasts and easing investor concerns over weak treasury results. Net revenue rose 3% year-over-year, while revenue excluding treasury results jumped 7%, signaling underlying business strength. Treasury income fell 19%, but the drop was less severe than markets anticipated.

  • Tight cost control helped — expenses were 2% below estimates, lifting profitability. As a result, EBITDA beat consensus by 4% and EPS by 5%, marking a welcome return to earnings momentum. Deutsche Boerse reaffirmed its full-year 2025 outlook, currently trading at 18.3× 2026 EPS and 12× EV/EBITDA.
  • Deutsche Börse delivered a strong third quarter, surprising analysts with better-than-expected results even amid low stock market volatility. The exchange operator earned €473 million in profit, a 6% increase year-over-year, exceeding consensus forecasts. 
  • According to new CFO Jens Schulte, earnings excluding treasury results rose 7%, showing the company’s resilience despite cyclical pressures in trading activity. For the full year, Deutsche Börse remains on track to meet its 2025 targets. Management continues to expect net revenue (ex-treasury) to climb roughly 9% to about €5.2 billion, while EBITDA should reach around €2.7 billion, up from €2.35 billion in the prior year.

In short, even with calmer markets, Deutsche Börse is proving it can generate steady growth — a reassuring signal for long-term. Deutsche Bank analyst maintained a Buy rating and €291 price target, saying the results “put an end to the recent negative earnings trends” and provide a strong setup for the December Capital Markets Day.

 
 
 

Source: xStation5

Symrise (SY1.DE, D1 interval)

 

Symrise Reports Slight Revenue Dip but Reaffirms Profit Targets

Symrise AG, the German producer of fragrances and flavorings, reported a modest decline in third-quarter revenue, reflecting slower market dynamics in parts of its portfolio. Revenue came in at €1.22 billion, down from €1.26 billion a year earlier, though organic sales still grew 1.4%. For the first nine months of the year, Symrise generated €3.78 billion in revenue, slightly below last year’s €3.82 billion, corresponding to 2.6% organic growth.

The company adjusted its full-year guidance, narrowing its organic growth forecast to 2.3%–3.3% (previously 3%–5%) but maintaining its EBITDA margin target around 21.5%. Looking ahead, Symrise reaffirmed its 2028 mid-term goals — targeting an organic compound annual growth rate (CAGR) of 5%–7% and an EBITDA margin between 21% and 23%. Despite near-term headwinds, Symrise continues to emphasize stable profitability and disciplined execution toward its long-term growth plan.

Source: xStation5

28 October 2025, 15:22

UnitedHealth Group: Q3 2025 Results and Outlook Point to a Recovery!

28 October 2025, 14:55

PayPay - Double digit gains on earnings and OpenAI cooperation

28 October 2025, 14:09

US OPEN: Quarterly Earnings Support U.S. Stock Gains

28 October 2025, 13:46

Wind turbine maker Nordex surges 19% to 9-year high 📈

This content has been created by XTB S.A. This service is provided by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, entered in the register of entrepreneurs of the National Court Register (Krajowy Rejestr Sądowy) conducted by District Court for the Capital City of Warsaw, XII Commercial Division of the National Court Register under KRS number 0000217580, REGON number 015803782 and Tax Identification Number (NIP) 527-24-43-955, with the fully paid up share capital in the amount of PLN 5.869.181,75. XTB S.A. conducts brokerage activities on the basis of the license granted by Polish Securities and Exchange Commission on 8th November 2005 No. DDM-M-4021-57-1/2005 and is supervised by Polish Supervision Authority.

Join over 1.7 Million investors from around the world